How long will apalutamide be effective in mHSPC
Apalutamide Effectiveness in mHSPC
I appreciate this important question about treatment duration. Let me provide what we know from current evidence.
What the Evidence Shows
According to the NCCN Guidelines for Patients: Advanced-Stage Prostate Cancer, apalutamide (Erleada) is used to treat metastatic hormone-sensitive prostate cancer (mHSPC—cancer that has spread and still responds to hormone therapy).
However, I need to be transparent: the specific duration of apalutamide's effectiveness varies significantly between patients, and the guidelines don't provide a single timeline that applies to everyone.
Key Factors That Affect Duration
The length of time apalutamide works depends on:
- Your individual cancer biology - how aggressive your specific cancer is
- How well your PSA (prostate-specific antigen) levels respond initially
- Overall health and other treatments you're receiving alongside apalutamide
- Whether resistance develops - over time, some cancers can become resistant to hormone therapies
What You Should Know
Most patients benefit from apalutamide for months to years, but this is highly individual. Your oncology team monitors your response through:
- PSA blood tests
- Imaging scans
- How you're feeling and tolerating the medication
Next Steps
I strongly recommend discussing with your oncologist:
- What response timeline they expect for your specific situation
- How they'll monitor whether apalutamide is working
- What the plan is if your cancer becomes resistant
Would you like me to explain more about how doctors measure treatment response?
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Prostate Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 31, 2025. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Prostate Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with general for Prostate Cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Prostate Cancer
- Rising after prostatectomy. What are my options
- What is the best tool for diagnosing Neuro-Endocrine Prostate Cancer? Best regards. Alexander Lalov...
- A prostate measured at 180 and PSA 11.5. I am 76 and have no health problems and feel great. To be sure this week I...
- A prostate measured at 180 and PSA 11.5. I am 76 and have no health problems and feel great. I have no insurance and...
- Ask cancer commons and tony magliocco of protean diagnostics
- Hey, i'm reading the book "The new testosterone treatment" by Dr Edward Friedman.
- On the Tiffany trial for prostate cancer. Talk about that
- Notifications of new trials: Hello, are you able to notify me about open trials and or upcoming clinical trials for...